Influence of ST2 and IL-33 on cardiac allograft vasculopathy and outcome
ST2 和 IL-33 对心脏同种异体移植血管病变和结局的影响
基本信息
- 批准号:8307148
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-22 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAlloantigenAllogenicAllograftingAnimal ModelAntigen-Presenting CellsApolipoprotein EArterial Fatty StreakAtherosclerosisBioinformaticsBiologicalCD4 Positive T LymphocytesCardiacCardiovascular systemCell ProliferationCellsChronicClinical ResearchDataDendritic CellsDevelopmentDoseEndothelial CellsEnvironmentEtiologyExposure toFailureFamily memberGene ActivationHeart DiseasesHeart TransplantationImmuneImmune responseImmunobiologyImmunosuppressive AgentsIn VitroInflammatoryInfusion proceduresInstructionInterferonsInterleukin-1Interleukin-12Interleukin-4Knockout MiceLigandsLigationMAP Kinase GeneMediatingModelingMolecularMorbidity - disease rateMusMyelogenousMyeloid CellsOutcomePatientsPhasePhysiologic pulsePopulationPostoperative PeriodPreventionPropertyProteinsRegulationRegulatory T-LymphocyteReportingResistanceSignal PathwaySignal TransductionSignaling Pathway GeneSirolimusSmooth Muscle MyocytesStagingStimulusStressSuppressor-Effector T-LymphocytesT cell responseT-LymphocyteTNFRSF5 geneTh1 CellsTh2 CellsTherapeuticToll-like receptorsTransplant RecipientsTransplantationUp-RegulationVaccinesVascular Diseasesallograft rejectionbasecell motilityconstrictioncytokinegraft failureheart allograftimprovedin vivoinsightisoimmunitymacrophagemigrationmortalitynoveloverexpressionpreventprotective effectreceptorresponse
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heth R Turnquist其他文献
Heth R Turnquist的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heth R Turnquist', 18)}}的其他基金
Immunoregulatory Mechanisms of IL-33 in Heart Transplantation
IL-33在心脏移植中的免疫调节机制
- 批准号:
10680570 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Immunoregulatory mechanisms of IL-33 in heart transplantation
IL-33在心脏移植中的免疫调节机制
- 批准号:
9096202 - 财政年份:2015
- 资助金额:
$ 24.9万 - 项目类别:
Immunoregulatory mechanisms of IL-33 in heart transplantation
IL-33在心脏移植中的免疫调节机制
- 批准号:
9476343 - 财政年份:2015
- 资助金额:
$ 24.9万 - 项目类别:
Influence of ST2 and IL-33 on cardiac allograft vasculopathy and outcome
ST2 和 IL-33 对心脏同种异体移植血管病变和结局的影响
- 批准号:
8322657 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别:
Influence of ST2 and IL-33 on cardiac allograft vasculopathy and outcome
ST2 和 IL-33 对心脏同种异体移植血管病变和结局的影响
- 批准号:
8522216 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别:
Influence of ST2 and IL-33 on cardiac allograft vasculopathy and outcome
ST2 和 IL-33 对心脏同种异体移植血管病变和结局的影响
- 批准号:
7714818 - 财政年份:2009
- 资助金额:
$ 24.9万 - 项目类别:
Mechanisms of immune regulation by rapamycin-conditioned dendritic cells
雷帕霉素条件树突状细胞的免疫调节机制
- 批准号:
7492150 - 财政年份:2007
- 资助金额:
$ 24.9万 - 项目类别:
Mechanisms of immune regulation by rapamycin-conditioned dendritic cells
雷帕霉素条件树突状细胞的免疫调节机制
- 批准号:
7223361 - 财政年份:2007
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
Operational tolerance induction by alloantigen-induced Treg cell therapy in rat lung transplantation
同种异体抗原诱导的 Treg 细胞疗法在大鼠肺移植中诱导操作耐受
- 批准号:
23K08289 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Selective induction of alloantigen-specific humoral tolerance by MHC-Fc fusion proteins
MHC-Fc 融合蛋白选择性诱导同种异体抗原特异性体液耐受
- 批准号:
10432434 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Requirements and mechanisms of alloantigen-induced cardiac allograft survival by cDC1s
cDC1同种异体抗原诱导心脏同种异体移植物存活的要求和机制
- 批准号:
10744193 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Requirements and mechanisms of alloantigen-induced cardiac allograft survival by cDC1s
cDC1同种异体抗原诱导心脏同种异体移植物存活的要求和机制
- 批准号:
10534556 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Selective induction of alloantigen-specific humoral tolerance by MHC-Fc fusion proteins
MHC-Fc 融合蛋白选择性诱导同种异体抗原特异性体液耐受
- 批准号:
10612453 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Preventing GVHD by inhibition of alloantigen presentation in the gut
通过抑制肠道内同种抗原的呈现来预防 GVHD
- 批准号:
10204102 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
Preventing GVHD by inhibition of alloantigen presentation in the gut
通过抑制肠道内同种抗原的呈现来预防 GVHD
- 批准号:
10443701 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
Preventing GVHD by inhibition of alloantigen presentation in the gut
通过抑制肠道内同种抗原的呈现来预防 GVHD
- 批准号:
10737340 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
Preventing GVHD by inhibition of alloantigen presentation in the gut
通过抑制肠道内同种抗原的呈现来预防 GVHD
- 批准号:
10652374 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
Generation of alloantigen-specific Designer Platelets for diagnostic and investigative use
生成用于诊断和研究用途的同种异体抗原特异性设计血小板
- 批准号:
9005358 - 财政年份:2016
- 资助金额:
$ 24.9万 - 项目类别:














{{item.name}}会员




